Artificial Tears Demand Soars As Dry Eye Disease Prevalence Increases: A Key Catalyst Accelerating Artificial Tears Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Tears Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recent years have seen a robust growth in the size of the artificial tears market. It is projected to expand from $3.55 billion in 2024 to $3.78 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. Factors such as an aging population, increased time spent on screens, healthcare spending, a shift from prescription to over-the-counter, and regulatory changes have contributed to the historic period's growth.

Artificial Tears Market Size Forecast: What's the Projected Valuation by 2029?
The market for artificial tears is projected to show substantial growth in the near future, rising to a size of $4.86 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth in the forecast period include an increase in incidence of dry eye syndrome, a rise in the use of contact lenses, urbanization on a global scale, growing pollution, and the boom of e-commerce. Significant trends anticipated during the forecast period include the progression of technology, the integration of AI and tech, collaborations with healthcare providers, the incorporation of natural ingredients, advancements in the formulation of products, advanced drug delivery systems, and sustainability in products that are eco-friendly.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

What Are the Drivers Transforming the Artificial Tears Market?
The artificial tear market is set to advance due to the increasing incidence of dry eye disease. When the eyes do not produce sufficient tears, or the tear quality is poor, it may lead to dry eye disease, causing discomfort and irritation. By supplementing the natural tear production, artificial tears can bring about relief and appropriate lubrication for dry eyes. For example, a study by Macquarie University in Australia in March 2022 found that 13% (15 out of 120) of over 5,000 participants aged 50 and older showed clinical indicators of dry eye disease. They classified these cases as 8.2% mild, 2.5% moderate, and 1.6% severe. In addition, Eyes On Eyecare, a digital news outlet focused on ophthalmology in the US, reported in March 2022 that the adoption of prescribed and clinical treatments for dry eye disease escalated from 5.8% in 2021 to 7.56% in 2022. Specifically, prescription treatments such as topical steroids witnessed a notable increase from 0.9% to 9.1% during the same timeframe. As such, the growing prevalence of dry eye disease underscores the upward movement of the artificial tear market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

What Long-Term Trends Will Define the Future of the Artificial Tears Market?
Key players in the artificial tears market are discovering products with innovative technologies like the patented pureflow technology to amplify product safety and usability. This proprietary technology comprises a unique delivery system that uses a one-way valve to assure the sterilized dispensation of preservative-free eye drops, thus averting contamination and preserving the integrity of the product. For example, Alcon Inc., a medical device and pharmaceutical firm based in Switzerland, introduced Systane Complete Preservative-Free Lubricant Eye Drops in January 2022. These superior artificial tears are distinctively designed to alleviate symptoms associated with various forms of dry eye, including evaporative dry eye and aqueous tear deficiency. Being preservative-free, they supply up to eight hours of sustained relief by moisturizing and safeguarding every layer of the tear film. With the assistance of nano-droplet technology, these drops provide quick hydration to the surface of the eye, preventing tear evaporation, and ensuring swift and effective comfort. Stored in a handy multi-dose bottle outfitted with PureFlow technology, the design ensures safety by warding off contamination, making it a top pick for consistent users and individuals with sensitive eyes.

Which Segments in the Artificial Tears Market Offer the Most Profit Potential?
The artificial tears market covered in this report is segmented -

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears
2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray
3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications
4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Subsegments:
1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears
2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears
3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears
4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears
5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears
6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13799&type=smp

Which Firms Dominate the Artificial Tears Market by Market Share and Revenue in 2025?
Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy's Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

Which Regions Offer the Highest Growth Potential in the Artificial Tears Market?
North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13799

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.